Stream Biomedical, Inc

📍 Houston, United States🗓 Founded 2016👥 5 employees💰 Last funded Jan 2019
Biotechnology Research🌐 streambiomedical.com
Website LinkedIn
Founded in 2016, Stream Biomedical is a clinical-stage biotechnology company developing LG3, a first-in-class protein designed to activate the brain’s natural repair mechanisms. The company is focused on restoring neurological function after injury or disease, including stroke, traumatic brain injury, and Alzheimer’s disease—conditions with few options that address underlying brain damage. LG3 is being developed as a regenerative biologic therapy that supports the brain’s intrinsic ability to heal by targeting multiple aspects of injury, including vascular dysfunction and inflammation.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Stream Biomedical, Inc?
Stream Biomedical, Inc has 1 investors on record on gritt.io, 1 mid-stage.
When did Stream Biomedical, Inc last raise funding?
The most recent investment in Stream Biomedical, Inc recorded on gritt.io was in January 2019.
When was Stream Biomedical, Inc founded?
Stream Biomedical, Inc was founded in 2016.
What industry is Stream Biomedical, Inc in?
Stream Biomedical, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Stream Biomedical, Inc based?
Stream Biomedical, Inc is headquartered in Houston, United States.